Skip to content

Research at St Andrews

Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation

Research output: Contribution to journalArticle

Author(s)

Adam Young, Elaine Catherine Campbell, Sarah Janice Lynch, John Suckling, Simon John Powis

School/Research organisations

Abstract

Autism spectrum condition (ASC) is recognized as having an inflammatory component. Post-mortem brain samples from patients with ASC display neuroglial activation and inflammatory markers in cerebrospinal fluid, although little is known about the underlying molecular mechanisms. Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) is a protein found in almost all cell types and mediates regulation of immune response by inducing the expression of inflammatory cytokines and chemokines, establishing a feedback mechanism that can produce chronic or excessive inflammation. This article describes immunodetection and immunofluorescence measurements of NF-κB in human post-mortem samples of orbitofrontal cortex tissue donated to two independent centers: London Brain Bank, Kings College London, UK (ASC: n = 3, controls: n = 4) and Autism Tissue Program, Harvard Brain Bank, USA (ASC: n = 6, controls: n = 5). The hypothesis was that concentrations of NF-κB would be elevated, especially in activated microglia in ASC, and pH would be concomitantly reduced (i.e., acidification). Neurons, astrocytes, and microglia all demonstrated increased extranuclear and nuclear translocated NF-κB p65 expression in brain tissue from ASC donors relative to samples from matched controls. These between-groups differences were increased in astrocytes and microglia relative to neurons, but particularly pronounced for highly mature microglia. Measurement of pH in homogenized samples demonstrated a 0.98-unit difference in means and a strong (F = 98.3; p = 0.00018) linear relationship to the expression of nuclear translocated NF-κB in mature microglia. Acridine orange staining localized pH reductions to lysosomal compartments. In summary, NF-κB is aberrantly expressed in orbitofrontal cortex in patients with ASC, as part of a putative molecular cascade leading to inflammation, especially of resident immune cells in brain regions associated with the behavioral and clinical symptoms of ASC.
Close

Details

Original languageEnglish
Article number27
Number of pages8
JournalFrontiers in Psychiatry
Volume2
DOIs
Publication statusPublished - 13 May 2011

    Research areas

  • Autism spectrum condition , Brain, Inflammation, Orbitofrontal cortex

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. High-content screening image dataset and quantitative image analysis of Salmonella infected human cells

    Antoniou, A. N., Powis, S. J. & Kriston-Vizi, J., 16 Dec 2019, In : BMC Research Notes. 12, 4 p., 808.

    Research output: Contribution to journalArticle

  2. Does natural killer cell deficiency (NKD) increase the risk of cancer? NKD may increase the risk of some virus induced cancer

    Moon, W. Y. & Powis, S. J., 19 Jul 2019, In : Frontiers in Immunology. 10, 5 p., 1703.

    Research output: Contribution to journalReview article

  3. Label-free optical hemogram of granulocytes enhanced by artificial neural networks

    Gupta, R., Chen, M., Malcolm, G. P. A., Hempler, N., Dholakia, K. & Powis, S. J., 13 May 2019, In : Optics Express. 27, 10, p. 13706-13720 15 p.

    Research output: Contribution to journalArticle

  4. Salmonella exploits HLA-B27 and host unfolded protein responses to promote intracellular replication

    Antoniou, A. N., Lenart, I., Kriston-Vizi, J., Iwawaki, T., Turmaine, M., McHugh, K., Ali, S., Blake, N., Bowness, P., Bajaj-Elliott, M., Gould, K., Nesbeth, D. & Powis, S. J., Jan 2019, In : Annals of the Rheumatic Diseases. 78, 1, p. 74–82 9 p., 213532.

    Research output: Contribution to journalArticle

Related by journal

  1. A roadmap for integrating neuroscience into addiction treatment: a consensus of the Neuroscience Interest Group of the International Society of Addiction Medicine

    Verdejo-Garcia, A., Lorenzetti, V., Manning, V., Piercy, H., Bruno, R., Hester, R., Pennington, D., Tolomeo, S., Arunogiri, S., Bates, M. E., Bowden-Jones, H., Campanella, S., Daughters, S. B., Kouimtsidis, C., Lubman, D. I., Meyerhoff, D. J., Ralph, A., Rezapour, T., Tavakoli, H., Zare-Bidoky, M. & 6 others, Zilverstand, A., Steele, D., Moeller, S. J., Paulus, M., Baldacchino, A. M. & Ekhtiari, H., 23 Dec 2019, In : Frontiers in Psychiatry. 10, p. 1-23 23 p., 877.

    Research output: Contribution to journalReview article

  2. Craving in opioid use disorder: from neurobiology to clinical practice

    Kakko, J., Alho, H., Baldacchino, A. M., Molina, R., Nava, F. A. & Shaya, G., 30 Aug 2019, In : Frontiers in Psychiatry. 10, 12 p., 592.

    Research output: Contribution to journalReview article

  3. Effects of opioid dependence on visuospatial memory and its associations with depression and anxiety

    Tolomeo, S., Davey, F., Steele, J. D. & Baldacchino, A. M., 23 Oct 2019, In : Frontiers in Psychiatry. 10, p. 1-8 8 p., 743.

    Research output: Contribution to journalArticle

ID: 10073156

Top